Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
650 JPY | +13.24% | +19.27% | -13.56% |
Business Summary
Number of employees: 13
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Royalty
100.0
%
| 56 | 14.3 % | 69 | 100.0 % | +23.26% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 392 | 100.0 % | 69 | 100.0 % | -82.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kiichi Adachi
CEO | Chief Executive Officer | 57 | 04-03-31 |
Yutaka Matsuura
ADM | Chief Administrative Officer | 55 | 17-09-30 |
Etsuro Hashimura
BRD | Director/Board Member | 72 | 16-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 18-11-30 | |
Kiichi Adachi
CEO | Chief Executive Officer | 57 | 04-03-31 |
Akihiro Tomoyasu
BRD | Director/Board Member | 53 | 16-11-30 |
Yutaka Matsuura
ADM | Chief Administrative Officer | 55 | 17-09-30 |
Etsuro Hashimura
BRD | Director/Board Member | 72 | 16-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 6,571,700 | 4,928,453 ( 75.00 %) | 87 ( 0.001324 %) | 75.00 % |
Company contact information
Kringle Pharma, Inc.
Saito Bio Incubator 207 7-7-15 Saitoasagi
567-0085, Osaka
+
http://www.kringle-pharma.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-13.56% | 24.29M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- 4884 Stock
- Company Kringle Pharma, Inc.